IL156234A0 - Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same - Google Patents
Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using sameInfo
- Publication number
- IL156234A0 IL156234A0 IL15623401A IL15623401A IL156234A0 IL 156234 A0 IL156234 A0 IL 156234A0 IL 15623401 A IL15623401 A IL 15623401A IL 15623401 A IL15623401 A IL 15623401A IL 156234 A0 IL156234 A0 IL 156234A0
- Authority
- IL
- Israel
- Prior art keywords
- making
- materials
- methods
- same
- derived therefrom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25394300P | 2000-11-30 | 2000-11-30 | |
PCT/US2001/044627 WO2002102997A2 (en) | 2000-11-30 | 2001-11-30 | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
Publications (1)
Publication Number | Publication Date |
---|---|
IL156234A0 true IL156234A0 (en) | 2004-01-04 |
Family
ID=22962299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15623401A IL156234A0 (en) | 2000-11-30 | 2001-11-30 | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same |
Country Status (12)
Country | Link |
---|---|
US (1) | US20020168763A1 (xx) |
EP (1) | EP1395652A2 (xx) |
JP (2) | JP2004532648A (xx) |
KR (2) | KR20080051191A (xx) |
CN (1) | CN100422315C (xx) |
AU (1) | AU2001297880B2 (xx) |
CA (1) | CA2430627A1 (xx) |
HK (1) | HK1081225A1 (xx) |
IL (1) | IL156234A0 (xx) |
NZ (1) | NZ526243A (xx) |
RU (1) | RU2322497C2 (xx) |
WO (1) | WO2002102997A2 (xx) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8273570B2 (en) * | 2000-05-16 | 2012-09-25 | Riken | Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells |
IL156746A0 (en) * | 2001-01-02 | 2004-02-08 | Stemron Inc | A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom and materials and method using same |
US8153424B2 (en) * | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US7588937B2 (en) * | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
CA2468171C (en) * | 2001-11-15 | 2015-10-06 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
JP4481652B2 (ja) | 2002-02-12 | 2010-06-16 | レイベン バイオテクノロジーズ,インコーポレイティド | ヒト胎児膀胱由来上皮細胞 |
US20040091936A1 (en) | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
CA2505598A1 (en) | 2002-05-24 | 2003-12-04 | Advanced Cell Technology, Inc. | A bank of stem cells for transplantation |
CN100549163C (zh) | 2002-12-16 | 2009-10-14 | 技术研究及发展基金有限公司 | 制备无饲养细胞、无异源的人胚胎干细胞的方法以及使用该方法制备的干细胞培养物 |
US20060223177A1 (en) | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US7875273B2 (en) | 2004-12-23 | 2011-01-25 | Ethicon, Incorporated | Treatment of Parkinson's disease and related disorders using postpartum derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
ES2564044T3 (es) | 2003-06-27 | 2016-03-17 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
KR20060115351A (ko) * | 2003-08-29 | 2006-11-08 | 위스콘신 얼럼나이 리서어치 화운데이션 | 영장류 배아 줄기 세포 기원의 신경 줄기 세포, 운동 뉴런및 도파민 뉴런의 시험관내 분화 방법 |
JP4499041B2 (ja) * | 2003-12-11 | 2010-07-07 | 独立行政法人科学技術振興機構 | 擬微小重力環境下での骨髄細胞を用いた3次元軟骨組織構築方法 |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
CA2549605C (en) | 2003-12-23 | 2013-05-07 | Cythera, Inc. | Definitive endoderm |
ATE506431T1 (de) | 2004-04-23 | 2011-05-15 | Bioe Llc | Mehrfachlinien-vorläuferzellen |
US7622108B2 (en) | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
KR101278421B1 (ko) * | 2004-04-27 | 2013-07-15 | 비아싸이트, 인크. | Pdx1 발현 내배엽 |
KR100644296B1 (ko) * | 2004-07-24 | 2006-11-10 | 정필훈 | 생체 공학적 턱뼈 및 치아 재건 방법 |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
AU2006286149B2 (en) | 2005-08-29 | 2012-09-13 | Technion Research And Development Foundation Ltd. | Media for culturing stem cells |
US20070128727A1 (en) * | 2005-11-08 | 2007-06-07 | Kraemer Fredric B | Methods for differentiation of embryonic stem cells |
PL1971681T3 (pl) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej |
WO2007073552A1 (en) | 2005-12-19 | 2007-06-28 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
SG169359A1 (en) * | 2006-01-31 | 2011-03-30 | Univ Keio | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
EP2019858B1 (en) | 2006-04-17 | 2012-06-13 | BioE LLC | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
CA2650685C (en) | 2006-04-28 | 2014-02-04 | Asubio Pharma Co., Ltd. | Method for inducing differentiation of pluripotent stem cells into cardiomyocytes |
US9040297B2 (en) | 2006-08-02 | 2015-05-26 | Technion Research & Development Foundation Limited | Methods of expanding embryonic stem cells in a suspension culture |
US20080108044A1 (en) * | 2006-11-08 | 2008-05-08 | Deepika Rajesh | In vitro differentiation of hematopoietic cells from primate embryonic stem cells |
ES2525718T3 (es) | 2007-10-05 | 2014-12-29 | DePuy Synthes Products, LLC | Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
GB0800524D0 (en) * | 2008-01-14 | 2008-02-20 | Univ Brighton | Cell culture system |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
CA2747794C (en) | 2008-12-19 | 2018-10-30 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of lung and pulmonary diseases and disorders |
SG174551A1 (en) | 2009-03-26 | 2011-10-28 | Ethicon Inc | Human umbilical cord tissue cells as therapy for alzheimer' s disease |
US20100247495A1 (en) * | 2009-03-30 | 2010-09-30 | Tom Ichim | Treatment of Muscular Dystrophy |
ES2932664T3 (es) | 2009-11-12 | 2023-01-23 | Technion Res & Dev Foundation | Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado |
WO2011157678A1 (en) * | 2010-06-14 | 2011-12-22 | Qiagen Gmbh | Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples |
PL2794854T3 (pl) | 2011-12-23 | 2018-12-31 | DePuy Synthes Products, Inc. | Wykrywanie ludzkich komórek pochodzących z tkanki pępowinowej |
ES2778098T3 (es) * | 2013-03-13 | 2020-08-07 | Univ Miami | Método de aislamiento y purificación de microvesículas de sobrenadantes de cultivo celular y fluidos biológicos |
JP6161828B2 (ja) * | 2015-04-20 | 2017-07-12 | 国立大学法人 岡山大学 | がんの非ヒトモデル動物及びその作製方法、がん幹細胞及びその製造方法 |
CN107338214B (zh) * | 2016-04-29 | 2020-04-17 | 湖南光琇高新生命科技有限公司 | 成纤维细胞及其制备方法和应用、细胞分泌液及其应用 |
JP6276487B1 (ja) * | 2016-07-19 | 2018-02-07 | 株式会社マンダム | 汗腺の動態の観察方法 |
KR102169122B1 (ko) * | 2016-12-29 | 2020-10-23 | 의료법인 성광의료재단 | 중간엽 줄기세포의 제조방법 |
SG11202100156UA (en) * | 2018-07-17 | 2021-02-25 | Univ California | Chimeric antigen receptor t cells derived from immunoengineered pluripotent stem cells |
CN109298174A (zh) * | 2018-09-26 | 2019-02-01 | 姜云瀚 | 一种多色免疫荧光标记方法和成像方法 |
CN113215081B (zh) * | 2021-06-01 | 2023-04-14 | 华中科技大学同济医学院附属同济医院 | 诱导干细胞分化为甲状旁腺细胞的方法及其组合物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
WO1993019166A1 (en) * | 1992-03-23 | 1993-09-30 | The University Of North Carolina At Chapel Hill | Small animal model for studying cholesterol metabolism |
GB9308271D0 (en) * | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517779D0 (en) * | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
US5905042A (en) * | 1996-04-01 | 1999-05-18 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Cultured inner cell mass cell lines derived from bovine or porcine embryos |
US5945577A (en) * | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
BR9811657A (pt) * | 1997-07-03 | 2000-09-05 | Univ Massachusetts Public Inst | Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro |
GB9809178D0 (en) * | 1998-04-29 | 1998-07-01 | Univ Edinburgh | Nuclear reprogramming of somatic cells |
US6469229B1 (en) * | 1998-08-20 | 2002-10-22 | The General Hospital Corporation | Inbred miniature swine and uses thereof |
ATE514772T1 (de) * | 1999-08-05 | 2011-07-15 | Abt Holding Co | Multipotente erwachsene stammzellen und verfahren zu deren isolierung |
JP2003514516A (ja) * | 1999-10-28 | 2003-04-22 | ユニバーシティ オブ マサチューセッツ | 多能性細胞と細胞株の雌性発生的または雄性発生的産生および分化した細胞と組織を産生するためのその使用 |
AU1581001A (en) * | 1999-11-02 | 2001-05-14 | University Of Massachusetts | Use of haploid genomes for genetic diagnosis, modification and multiplication |
WO2001059076A2 (en) * | 2000-02-09 | 2001-08-16 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses |
GB0025088D0 (en) * | 2000-10-13 | 2000-11-29 | Univ Edinburgh | Stem cells |
GB0026252D0 (en) * | 2000-10-26 | 2000-12-13 | Univ Edinburgh | Pluripotential stem cells |
US20030027331A1 (en) * | 2000-11-30 | 2003-02-06 | Yan Wen Liang | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same |
IL156746A0 (en) * | 2001-01-02 | 2004-02-08 | Stemron Inc | A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom and materials and method using same |
-
2001
- 2001-11-30 CN CNB018223958A patent/CN100422315C/zh not_active Expired - Fee Related
- 2001-11-30 NZ NZ526243A patent/NZ526243A/en unknown
- 2001-11-30 CA CA002430627A patent/CA2430627A1/en not_active Abandoned
- 2001-11-30 EP EP01274145A patent/EP1395652A2/en not_active Withdrawn
- 2001-11-30 WO PCT/US2001/044627 patent/WO2002102997A2/en active IP Right Grant
- 2001-11-30 JP JP2003506451A patent/JP2004532648A/ja active Pending
- 2001-11-30 KR KR1020087012507A patent/KR20080051191A/ko not_active Application Discontinuation
- 2001-11-30 RU RU2003119168/13A patent/RU2322497C2/ru not_active IP Right Cessation
- 2001-11-30 IL IL15623401A patent/IL156234A0/xx unknown
- 2001-11-30 KR KR10-2003-7007343A patent/KR20030088022A/ko not_active Application Discontinuation
- 2001-11-30 AU AU2001297880A patent/AU2001297880B2/en not_active Ceased
- 2001-11-30 US US09/997,240 patent/US20020168763A1/en not_active Abandoned
-
2006
- 2006-01-23 HK HK06100997.7A patent/HK1081225A1/xx not_active IP Right Cessation
-
2008
- 2008-10-01 JP JP2008256603A patent/JP2009028049A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20030088022A (ko) | 2003-11-15 |
AU2001297880B2 (en) | 2007-05-31 |
CA2430627A1 (en) | 2002-12-27 |
RU2322497C2 (ru) | 2008-04-20 |
KR20080051191A (ko) | 2008-06-10 |
JP2004532648A (ja) | 2004-10-28 |
HK1081225A1 (en) | 2006-05-12 |
WO2002102997A3 (en) | 2003-12-24 |
AU2001297880B8 (en) | 2003-01-02 |
RU2003119168A (ru) | 2005-02-20 |
WO2002102997A2 (en) | 2002-12-27 |
JP2009028049A (ja) | 2009-02-12 |
US20020168763A1 (en) | 2002-11-14 |
CN1643135A (zh) | 2005-07-20 |
EP1395652A2 (en) | 2004-03-10 |
NZ526243A (en) | 2006-02-24 |
CN100422315C (zh) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL156234A0 (en) | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same | |
IL153095A0 (en) | Embryonic stem cells, methods for culturing the same and methods utilizing the same | |
IL152106A0 (en) | Embryonic stem cells, neural progenitor cells derived therefrom and methods for the preparation thereof | |
MXPA01008271A (es) | Celda secundaria y metodo para su preparacion. | |
IL142748A0 (en) | Embryonic stem cells | |
IL204766A (en) | Embryonic stem cells and nerve cells derived from them | |
AU2002230669A1 (en) | Postmortem stem cells | |
GB2407821B (en) | Stem Cells | |
MXPA02003733A (es) | Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas. | |
AU2003247514A8 (en) | Meningeal-derived stem cells | |
AU2001286315A1 (en) | Stem cell-like cells | |
EP1312668A4 (en) | CULTURE MEDIUM FOR STEM CELLS, CULTIVATION METHOD AND METHOD FOR USE THEREOF | |
TW500033U (en) | Open/close type chuck | |
GB0026252D0 (en) | Pluripotential stem cells | |
AU2001290078A1 (en) | Stem cell therapy | |
AU6438901A (en) | Protein translocation into plant cells | |
IL139322A0 (en) | Process for obtaining stem cells | |
HK1052380A1 (en) | Utility lighter. | |
AU1154802A (en) | Single cell electroporation | |
GB2351296B (en) | Keratinocyte stem cells | |
AU1368402A (en) | Cell reprogramming | |
AU4520101A (en) | Lung stem cells and lung regeneration | |
AU3860101A (en) | Utility lighter | |
GB0025088D0 (en) | Stem cells | |
GB0229261D0 (en) | Cells,culture methods and their uses |